India Covid-19 Detection Kit Market Scope
In response to the growing COVID-19 epidemic and lack of laboratory-based molecular testing ability, several diagnostic test manufacturers have developed and started selling quick and easy-to-use devices to enable testing outside of laboratory settings. The test kits are simple to use and are based either on the detection of proteins from the COVID-19 virus in respiratory samples like sputum, throat swab, or detection, in blood or serum, of human antibodies generated in response to infection. In January 2020, India had only one laboratory testing for COVID-19 at the Indian Council of Medical Research's National Institute of Virology, Pune. Today, there are approx. 555 laboratories across the country, performing molecular tests for diagnosis of COVID-19, an unparalleled achievement in the history of the Indian health system. The RT-PCR test for COVID-19, although increasingly available around the country today, involves multiple, complex steps. First, is the sample collection using throat or nasal swabs, which are then kept in a special fluid called viral transport medium (VTM). To expedite kits produced by the industry and reduce the burden of NIV, 14 validation centers have been approved. As many as 71 kits have been evaluated to date and 28 have been approved for use. Out of these, 14 kits were indigenous ones, paving the way for self-sufficiency in testing. In order to ensure that the supplies reached every laboratory in a timely manner amid the nationwide lockdown.
The market study is being classified by Type (RT-PCR Assay Kits, Immunoassay Test Strips/Cassettes, ELISA (Enzyme-Linked Immunosorbent Assay) and Feluda) and major geographies with country level break-up.
Zydus Cadila Pharmaceutical (India), Tulips Diagnostic (India), Johnson and Johnson Medical India (India), Genei Laboratories (India), SD Biosensor (South Korea), Altona Diagnostics (Germany) and Mylab Discovery Solutions Pvt. Ltd. (India) are some of the key players profiled in the study.
AdvanceMarketAnalytics has segmented the market of India India Covid-19 Detection Kit market by Type, Application and Region.
On the basis of geography, the market of India Covid-19 Detection Kit has been segmented into .
From a regulatory standpoint, such kits fall under the category of ‘in-vitro diagnostic’ kits under the Drugs and Cosmetics Act, 1940 (D&C Act). FDA/CDSCO and is compliant with MDR 2017 regulation for manufacturing medical devices of Class C and D, the most stringent and regulated products by the government.
- Increasing Technological Advancements in Virus Detection
- Rising Incidence of COVID-19
- High Risk of Infection in Geriatric Population
- Increasing Government and Industry Players Initiatives
- Lower Accuracy of immunoassay-Based Tests
Key Target AudienceManufacturers of COVID-19 Detective Kit, Suppliers of COVID-19 Detective Kit, Distributors and Retailers of COVID-19 Detective Kit and Governmental Bodies
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase